Free Trial

PFA Pension Forsikringsaktieselskab Invests $52.12 Million in Synopsys, Inc. $SNPS

Synopsys logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • PFA Pension Forsikringsaktieselskab purchased a new position of 109,852 shares valued at $52.12 million in Synopsys, representing 0.06% of the company at quarter-end, while institutional investors own 85.47% of the stock.
  • Synopsys beat quarterly expectations with $3.77 EPS (vs. $3.56 est.) and $2.41B revenue (up 65.6% YoY), and set FY2026 guidance of EPS 14.380–14.460.
  • The company has a market capitalization of $93.68 billion and a PE of 75.93, and analysts' consensus is a "Hold" rating with an average target price of $531.
  • MarketBeat previews the top five stocks to own by June 1st.

PFA Pension Forsikringsaktieselskab purchased a new position in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 109,852 shares of the semiconductor company's stock, valued at approximately $52,124,000. PFA Pension Forsikringsaktieselskab owned 0.06% of Synopsys at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Alpine Bank Wealth Management lifted its stake in Synopsys by 89.3% in the 3rd quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company's stock valued at $26,000 after purchasing an additional 25 shares during the last quarter. TFC Financial Management Inc. lifted its stake in Synopsys by 1,250.0% in the 3rd quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company's stock valued at $27,000 after purchasing an additional 50 shares during the last quarter. Millstone Evans Group LLC bought a new position in Synopsys in the 3rd quarter valued at approximately $27,000. SOA Wealth Advisors LLC. bought a new position in Synopsys in the 3rd quarter valued at approximately $28,000. Finally, Thurston Springer Miller Herd & Titak Inc. bought a new position in Synopsys in the 4th quarter valued at approximately $28,000. Institutional investors own 85.47% of the company's stock.

Synopsys Price Performance

Shares of NASDAQ SNPS opened at $489.02 on Friday. Synopsys, Inc. has a twelve month low of $376.18 and a twelve month high of $651.73. The firm has a fifty day simple moving average of $430.07 and a 200 day simple moving average of $445.70. The company has a market capitalization of $93.68 billion, a PE ratio of 75.93, a P/E/G ratio of 3.99 and a beta of 1.25. The company has a quick ratio of 1.26, a current ratio of 1.36 and a debt-to-equity ratio of 0.33.

Synopsys (NASDAQ:SNPS - Get Free Report) last posted its quarterly earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 EPS for the quarter, topping analysts' consensus estimates of $3.56 by $0.21. The business had revenue of $2.41 billion during the quarter, compared to analysts' expectations of $2.39 billion. Synopsys had a net margin of 13.76% and a return on equity of 6.83%. The business's quarterly revenue was up 65.6% on a year-over-year basis. During the same period last year, the company posted $3.03 earnings per share. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. On average, sell-side analysts forecast that Synopsys, Inc. will post 10.3 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on SNPS shares. Weiss Ratings reissued a "hold (c)" rating on shares of Synopsys in a research note on Thursday, January 22nd. HSBC downgraded shares of Synopsys from a "buy" rating to a "hold" rating and set a $455.00 price target for the company. in a research note on Friday, February 20th. Wells Fargo & Company dropped their price target on shares of Synopsys from $500.00 to $450.00 and set an "equal weight" rating for the company in a research note on Thursday, February 26th. Piper Sandler dropped their price target on shares of Synopsys from $520.00 to $430.00 and set a "neutral" rating for the company in a research note on Thursday, February 26th. Finally, Morgan Stanley reaffirmed an "equal weight" rating and set a $480.00 price target (down from $550.00) on shares of Synopsys in a research note on Wednesday, February 25th. Eight analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Synopsys presently has an average rating of "Hold" and an average target price of $531.00.

Check Out Our Latest Stock Analysis on Synopsys

Synopsys Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Featured Stories

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines